Literature DB >> 6703826

Complications associated with Staphylococcus aureus bacteremia.

H Libman, R D Arbeit.   

Abstract

Thirty-nine consecutive Staphylococcus aureus bacteremias were reviewed with particular attention to complications. Thirty-four (87%) of the bacteremias were nosocomial, with intravascular catheters (20 episodes) and dialysis-access sites (six episodes) the most common sources. Complications developed in 36% (14/39) of all bacteremias and in 30% (6/20) of those that were catheter-associated. Acute complications (shock, adult respiratory distress syndrome, disseminated intravascular coagulation) occurred in six patients and were fatal in four. In nine patients metastatic suppurative complications developed, six at sites of preexisting abnormalities. There were no episodes of endocarditis. Most patients received prolonged antibiotic therapy, and the majority of all suppurative complications required surgical intervention. Staphylococcus aureus bacteremia, even when not associated with endocarditis, is a cause of considerable morbidity and mortality in hospitalized patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6703826

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  28 in total

1.  An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection.

Authors:  Clare E Miller; Rahul Batra; Ben S Cooper; Amita K Patel; John Klein; Jonathan A Otter; Theodore Kypraios; Gary L French; Olga Tosas; Jonathan D Edgeworth
Journal:  Clin Infect Dis       Date:  2011-12-20       Impact factor: 9.079

Review 2.  Infections associated with medical devices: pathogenesis, management and prophylaxis.

Authors:  Christof von Eiff; Bernd Jansen; Wolfgang Kohnen; Karsten Becker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E.

Authors:  A Genovese; J P Bouvet; G Florio; B Lamparter-Schummert; L Björck; G Marone
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.

Authors:  C W Stratton; C Liu; L S Weeks
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

5.  Rapid identification of methicillin-resistant Staphylococcus aureus from positive blood cultures by real-time fluorescence PCR.

Authors:  T Y Tan; S Corden; R Barnes; B Cookson
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

6.  Methicillin-resistant Staphylococcus aureus: a continuing infection control challenge.

Authors:  J M Boyce
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

7.  Non-tropical pyomyositis.

Authors:  I Muscat; P P Anthony; J G Cruickshank
Journal:  J Clin Pathol       Date:  1986-10       Impact factor: 3.411

8.  Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus.

Authors:  M Pujol; C Peña; R Pallares; J Ayats; J Ariza; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

9.  In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source.

Authors:  A S Bayer; D Cheng; M R Yeaman; G R Corey; R S McClelland; L J Harrel; V G Fowler
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

10.  Infectious Disease Consultation for Staphylococcus aureus Bacteremia Improves Patient Management and Outcomes.

Authors:  Alexa A Pragman; Michael A Kuskowski; James M Abraham; Gregory A Filice
Journal:  Infect Dis Clin Pract (Baltim Md)       Date:  2012-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.